F6Publishing

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Articles Published Processes

Keyword: Sustained virologic response

Page 1 of 1 ( 28 items )
<<
1
>>

1	Effectiveness and safety of generic and brand direct acting antivirals for the treatment of chronic hepatitis C 12/2/2022 12:50:19 PM \| Browse: 389 \| Download: 1240
2	Best therapy for the easiest to treat hepatitis C virus genotype 1b-infected patients 12/2/2022 9:49:51 AM \| Browse: 466 \| Download: 1176
3	Hepatocellular carcinoma, decompensation, and mortality based on hepatitis C treatment: A prospective cohort study 8/10/2022 8:23:14 AM \| Browse: 435 \| Download: 1543
4	Hepatitis C virus burden: Treating and educating people without prejudice 7/27/2022 1:17:38 PM \| Browse: 468 \| Download: 1452
5	Benign course of residual inflammation at end of treatment of liver transplant recipients after sofosbuvir based therapy 3/24/2022 2:13:21 PM \| Browse: 516 \| Download: 1704
6	Real-world effectiveness of direct-acting antivirals in people living with human immunodeficiency virus and hepatitis C virus genotype 6 infections 3/17/2022 3:25:03 AM \| Browse: 454 \| Download: 1306
7	Association between direct-acting antiviral agents in hepatitis C virus treatment and hepatocellular carcinoma occurrence and recurrence: The endless debate 2/23/2022 3:51:55 PM \| Browse: 505 \| Download: 1518
8	Direct-acting antivirals for chronic hepatitis C treatment: The experience of two tertiary university centers in Brazil 1/21/2022 8:16:14 AM \| Browse: 587 \| Download: 1316
9	Dynamics of cytokines predicts risk of hepatocellular carcinoma among chronic hepatitis C patients after viral eradication 12/31/2021 12:21:18 PM \| Browse: 698 \| Download: 2086
10	Hepatocellular carcinoma risk after viral response in hepatitis C virus-advanced fibrosis: Who to screen and for how long? 10/27/2021 7:14:11 AM \| Browse: 627 \| Download: 1326
11	Recently acquired hepatitis C virus infection among people living with human immunodeficiency virus at a university hospital in Taiwan 9/29/2021 11:12:00 AM \| Browse: 530 \| Download: 1487
12	Factors influencing the failure of interferon-free therapy for chronic hepatitis C: Data from the Polish EpiTer-2 cohort study 5/10/2021 7:46:10 AM \| Browse: 486 \| Download: 1470
13	Metabolic and cardiovascular complications after virological cure in hepatitis C: What awaits beyond 4/29/2021 2:12:02 AM \| Browse: 541 \| Download: 1295
14	M2BPGi for assessing liver fibrosis in patients with hepatitis C treated with direct-acting antivirals 6/6/2020 2:43:56 PM \| Browse: 1184 \| Download: 2429
15	Sustained virologic response to direct-acting antiviral agents predicts better outcomes in hepatitis C virus-infected patients: A retrospective study 10/28/2019 11:23:12 AM \| Browse: 1021 \| Download: 2503
16	Consensus on management of hepatitis C virus infection in resource-limited Ukraine and Commonwealth of Independent States regions 8/7/2019 7:09:17 AM \| Browse: 1144 \| Download: 1953
17	Hepatitis C virus cure with direct-acting antivirals: Clinical, economic, societal and patient value for China 5/27/2019 8:24:36 AM \| Browse: 1069 \| Download: 1993
18	Hepatitis C virus-associated hepatocellular carcinoma after sustained virologic response 12/27/2018 9:28:07 AM \| Browse: 1068 \| Download: 1518
19	Factors associated with success of telaprevir- and boceprevir-based triple therapy for hepatitis C virus infection 4/13/2017 3:45:15 PM \| Browse: 1374 \| Download: 2573
20	Hepatitis C virus therapy with peg-interferon and ribavirin in Myanmar: A resource-constrained country 11/18/2016 3:13:00 PM \| Browse: 1139 \| Download: 2521
21	Boceprevir plus peginterferon/ribavirin for treatment of chronic hepatitis C in Russia 2/22/2016 3:38:00 PM \| Browse: 1230 \| Download: 2637
22	Treatment strategies for chronic hepatitis C prior to and following liver transplantation 1/7/2016 12:14:00 PM \| Browse: 1141 \| Download: 1835
23	Update on hepatitis C: Direct-acting antivirals 12/4/2015 3:24:00 PM \| Browse: 1219 \| Download: 2109
24	Is the use of IL28B genotype justified in the era of interferon-free treatments for hepatitis C? 8/13/2015 10:30:00 AM \| Browse: 1292 \| Download: 1965
25	Interferon-λ polymorphisms and response to pegylated interferon in Iranian hepatitis C patients 8/8/2015 3:25:00 PM \| Browse: 1195 \| Download: 2601
26	Predictive factors associated with hepatitis C antiviral therapy response 6/29/2015 5:40:00 PM \| Browse: 1220 \| Download: 1987
27	Interferon-3 polymorphisms in pegylated-interferon- plus ribavirin therapy for genotype-2 chronic hepatitis C 4/7/2015 6:08:00 PM \| Browse: 1100 \| Download: 1984
28	Sofosbuvir and ABT-450: Terminator of hepatitis C virus? 9/16/2014 9:54:00 AM \| Browse: 1450 \| Download: 1404

Page 1 of 1 ( 28 items )
<<
1
>>

1	Effectiveness and safety of generic and brand direct acting antivirals for the treatment of chronic hepatitis C 12/2/2022 12:50:19 PM \| Browse: 389 \| Download: 1240
2	Best therapy for the easiest to treat hepatitis C virus genotype 1b-infected patients 12/2/2022 9:49:51 AM \| Browse: 466 \| Download: 1176
3	Hepatocellular carcinoma, decompensation, and mortality based on hepatitis C treatment: A prospective cohort study 8/10/2022 8:23:14 AM \| Browse: 435 \| Download: 1543
4	Hepatitis C virus burden: Treating and educating people without prejudice 7/27/2022 1:17:38 PM \| Browse: 468 \| Download: 1452
5	Benign course of residual inflammation at end of treatment of liver transplant recipients after sofosbuvir based therapy 3/24/2022 2:13:21 PM \| Browse: 516 \| Download: 1704
6	Real-world effectiveness of direct-acting antivirals in people living with human immunodeficiency virus and hepatitis C virus genotype 6 infections 3/17/2022 3:25:03 AM \| Browse: 454 \| Download: 1306
7	Association between direct-acting antiviral agents in hepatitis C virus treatment and hepatocellular carcinoma occurrence and recurrence: The endless debate 2/23/2022 3:51:55 PM \| Browse: 505 \| Download: 1518
8	Direct-acting antivirals for chronic hepatitis C treatment: The experience of two tertiary university centers in Brazil 1/21/2022 8:16:14 AM \| Browse: 587 \| Download: 1316
9	Dynamics of cytokines predicts risk of hepatocellular carcinoma among chronic hepatitis C patients after viral eradication 12/31/2021 12:21:18 PM \| Browse: 698 \| Download: 2086
10	Hepatocellular carcinoma risk after viral response in hepatitis C virus-advanced fibrosis: Who to screen and for how long? 10/27/2021 7:14:11 AM \| Browse: 627 \| Download: 1326
11	Recently acquired hepatitis C virus infection among people living with human immunodeficiency virus at a university hospital in Taiwan 9/29/2021 11:12:00 AM \| Browse: 530 \| Download: 1487
12	Factors influencing the failure of interferon-free therapy for chronic hepatitis C: Data from the Polish EpiTer-2 cohort study 5/10/2021 7:46:10 AM \| Browse: 486 \| Download: 1470
13	Metabolic and cardiovascular complications after virological cure in hepatitis C: What awaits beyond 4/29/2021 2:12:02 AM \| Browse: 541 \| Download: 1295
14	M2BPGi for assessing liver fibrosis in patients with hepatitis C treated with direct-acting antivirals 6/6/2020 2:43:56 PM \| Browse: 1184 \| Download: 2429
15	Sustained virologic response to direct-acting antiviral agents predicts better outcomes in hepatitis C virus-infected patients: A retrospective study 10/28/2019 11:23:12 AM \| Browse: 1021 \| Download: 2503
16	Consensus on management of hepatitis C virus infection in resource-limited Ukraine and Commonwealth of Independent States regions 8/7/2019 7:09:17 AM \| Browse: 1144 \| Download: 1953
17	Hepatitis C virus cure with direct-acting antivirals: Clinical, economic, societal and patient value for China 5/27/2019 8:24:36 AM \| Browse: 1069 \| Download: 1993
18	Hepatitis C virus-associated hepatocellular carcinoma after sustained virologic response 12/27/2018 9:28:07 AM \| Browse: 1068 \| Download: 1518
19	Factors associated with success of telaprevir- and boceprevir-based triple therapy for hepatitis C virus infection 4/13/2017 3:45:15 PM \| Browse: 1374 \| Download: 2573
20	Hepatitis C virus therapy with peg-interferon and ribavirin in Myanmar: A resource-constrained country 11/18/2016 3:13:00 PM \| Browse: 1139 \| Download: 2521
21	Boceprevir plus peginterferon/ribavirin for treatment of chronic hepatitis C in Russia 2/22/2016 3:38:00 PM \| Browse: 1230 \| Download: 2637
22	Treatment strategies for chronic hepatitis C prior to and following liver transplantation 1/7/2016 12:14:00 PM \| Browse: 1141 \| Download: 1835
23	Update on hepatitis C: Direct-acting antivirals 12/4/2015 3:24:00 PM \| Browse: 1219 \| Download: 2109
24	Is the use of IL28B genotype justified in the era of interferon-free treatments for hepatitis C? 8/13/2015 10:30:00 AM \| Browse: 1292 \| Download: 1965
25	Interferon-λ polymorphisms and response to pegylated interferon in Iranian hepatitis C patients 8/8/2015 3:25:00 PM \| Browse: 1195 \| Download: 2601
26	Predictive factors associated with hepatitis C antiviral therapy response 6/29/2015 5:40:00 PM \| Browse: 1220 \| Download: 1987
27	Interferon-3 polymorphisms in pegylated-interferon- plus ribavirin therapy for genotype-2 chronic hepatitis C 4/7/2015 6:08:00 PM \| Browse: 1100 \| Download: 1984
28	Sofosbuvir and ABT-450: Terminator of hepatitis C virus? 9/16/2014 9:54:00 AM \| Browse: 1450 \| Download: 1404